https://canceradvocacy.org/wp-content/uploads/2017/01/ProtectOurCare-1024px.jpg
512
1024
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2017-02-13 18:09:252017-02-13 18:09:25ACA Update | February 13, 2017: More of the Same from Congressional RepublicansNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
News
https://canceradvocacy.org/wp-content/uploads/2017/01/ProtectOurCare-1024px.jpg
512
1024
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
actualizedevs2017-02-13 18:09:252017-02-13 18:09:25ACA Update | February 13, 2017: More of the Same from Congressional Republicans
What Caught Our Eye: ACA Analysis/Debate, Doc/Patient Communication, Universal Cancer Care, Financial Toxicity, Palliative Care Pain Studies
As the repeal and replace debate continues in Washington, the Brookings Institution spearheaded a study to look at what is and isn’t working with the Affordable Care Act. Their look at five states who implemented the ACA in various ways is informative to help inform where we go from here.

What Caught Our Eye: ACA Uncertainty, Coping Post-Treatment, Biden’s New Research Charity, Survivorship Care Plans
A new study by the Associated Press-NORC Center for Public Affairs Research found that only 16% of Americans feel the ACA should be repealed immediately. | Last weekend, Republican members of Congress gathered in Philadelphia, PA for a party retreat to address some of the most pressing topics. However, one topic remains without consensus is how they will approach the repeal and replacement of the Affordable Care Act.

ACA Update | February 3, 2017: Inadequate Replacement Plans
There remains no consensus among Republicans around a replacement plan for the ACA. In fact, more replacement proposals were presented, and after NCCS analyzed these proposals, we found that they do not come close to the level of protections the ACA provides currently and are therefore not adequate for cancer survivors.

What Caught Our Eye: ACA Debate, Thyroid Cancer Late Effects, Long-Term Follow-Up Care, Cervical Cancer Mortality, and Anxiety in Partners of Breast Cancer Survivors
For millions of cancer survivors and their families, Rep. Tom Price’s refusal to promise that no one will lose coverage because of President Trump’s executive order is unnerving to say the least.

ACA Update | January 26, 2017: Watch Our ACA Webinar
President Donald Trump and the Republican leadership in Congress will soon be making good on their campaign promise to repeal the Affordable Care Act (ACA). While replacement plans have been proposed, there is no consensus on an alternative.

ACA Update | January 24, 2017: The Cassidy-Collins Plan & ACA Executive Order
In early January, Congressional Republicans took the first steps toward repealing the ACA. Significant public outcry at the prospect of repealing the ACA without a replacement plan has been effective, as both legislators and the new administration now indicate that a replacement needs to be considered at the same time as repeal efforts.

Ask Your Oncologist About Clinical Drug Trials
If you had asked me in December 2012 if I would ever participate in a clinical drug trial, my answer would have been a resounding, “No.” The very word “trial” scared me off; I didn’t want to be a guinea pig, a test subject. I wanted proven medicine.

